Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP712507.RAgIqS2OO2a563ocb92NF6Ah75UswgOcluSTmrxgZOW68130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP712507.RAgIqS2OO2a563ocb92NF6Ah75UswgOcluSTmrxgZOW68130_assertion type Assertion NP712507.RAgIqS2OO2a563ocb92NF6Ah75UswgOcluSTmrxgZOW68130_head.
- NP712507.RAgIqS2OO2a563ocb92NF6Ah75UswgOcluSTmrxgZOW68130_assertion description "[GEP NETs occur either sporadically or as part of endocrine tumor susceptibility syndromes such as multiple endocrine neoplasia type 1 (MEN1), von Hippel Lindau (VHL) syndrome, neurofibromatosis (NF-1), and possibly tuberous sclerosis (TSC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP712507.RAgIqS2OO2a563ocb92NF6Ah75UswgOcluSTmrxgZOW68130_provenance.
- NP712507.RAgIqS2OO2a563ocb92NF6Ah75UswgOcluSTmrxgZOW68130_assertion evidence source_evidence_literature NP712507.RAgIqS2OO2a563ocb92NF6Ah75UswgOcluSTmrxgZOW68130_provenance.
- NP712507.RAgIqS2OO2a563ocb92NF6Ah75UswgOcluSTmrxgZOW68130_assertion SIO_000772 19125015 NP712507.RAgIqS2OO2a563ocb92NF6Ah75UswgOcluSTmrxgZOW68130_provenance.
- NP712507.RAgIqS2OO2a563ocb92NF6Ah75UswgOcluSTmrxgZOW68130_assertion wasDerivedFrom befree-2016 NP712507.RAgIqS2OO2a563ocb92NF6Ah75UswgOcluSTmrxgZOW68130_provenance.
- NP712507.RAgIqS2OO2a563ocb92NF6Ah75UswgOcluSTmrxgZOW68130_assertion wasGeneratedBy ECO_0000203 NP712507.RAgIqS2OO2a563ocb92NF6Ah75UswgOcluSTmrxgZOW68130_provenance.